formulation deharadoon
DESCRIPTION
PPT Slides for Formulation unitTRANSCRIPT
![Page 1: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/1.jpg)
FINISHED DOSAGE MANUFACTURING
FACILTYTablets & Capsules
(LOCATION-DEHRADUN)
![Page 2: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/2.jpg)
![Page 3: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/3.jpg)
![Page 4: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/4.jpg)
![Page 5: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/5.jpg)
![Page 6: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/6.jpg)
![Page 7: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/7.jpg)
![Page 8: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/8.jpg)
![Page 9: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/9.jpg)
![Page 10: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/10.jpg)
![Page 11: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/11.jpg)
![Page 12: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/12.jpg)
![Page 13: Formulation deharadoon](https://reader036.vdocuments.us/reader036/viewer/2022062418/5563b840d8b42ad83c8b4b21/html5/thumbnails/13.jpg)
Salient Features• Certified by
UKMHRA,INVIMA(Colombia),NDA Uganda,SDA Yemen,MSS Namibia
• Annual Capacity• Tablets – 2500 Million,Capsules – 750 Million• Other Dosage Forms : Oncology,Injectables
(Antibiotics),Ointments & Creams (Dermatology), Liquid Orals,Suppositories